Robert I. Blum
20 stock trades in the last 12 months, shares they bought or sold themselves (not grants or options).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
The 3 newest of 20 trades
| Stock | Trade | Amount | Traded |
|---|---|---|---|
| Sell(10b5-1 plan) | $401K | Nov 16SEC filing | |
| Sell(10b5-1 plan) | $471K | Nov 2SEC filing | |
| Sell(10b5-1 plan) | $472K | Oct 12SEC filing |
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Robert I. Blum's companies
| Stock | Trades | Quality Score |
|---|---|---|
| 20 |
Alerts for Robert I. Blum
Use this page
How to cite
Breakaway, Robert I. Blum: President & CEO at Cytokinetics (CYTK), Nov 18, 2026, getbreakaway.com/insiders/robert-i-blum
Journalists: email support@getbreakaway.com for the data behind this page.